Basic Information
| LncRNA/CircRNA Name | SATB2-AS1 |
| Synonyms | NA |
| Region | GRCh38_2:199457700-199476935 |
| Ensemble | ENSG00000225953 |
| Refseq | NR_026830 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | qPCR, RIP |
| Sample | colorectal carcinoma tissues and cell lines(NCM460) |
| Expression Pattern | down-regulated |
| Function Description | Of interest, the expression of lncRNA SATB2-AS1 (AK056625) was downregulated in the colorectal carcinoma tissues with metastasis. |
| Pubmed ID | 30858153 |
| Year | 2019 |
| Title | SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial-Mesenchymal Transition. |
External Links
| Links for SATB2-AS1 | GenBank HGNC NONCODE |
| Links for Colorectal cancer | OMIM COSMIC |